- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Multi-gene Next Generation Sequencing Panel
- Genetic
- Lead sponsor
- Ambry Genetics
- Industry
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 3
- States / cities
- Scottsdale, Arizona • Boston, Massachusetts • Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 24, 2020 · Synced May 21, 2026, 10:13 PM EDT